Bausch Financial Statements From 2010 to 2024

BHC Stock  USD 8.66  0.08  0.92%   
Bausch Health financial statements provide useful quarterly and yearly information to potential Bausch Health Companies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bausch Health financial statements helps investors assess Bausch Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bausch Health's valuation are summarized below:
Gross Profit
5.8 B
Profit Margin
(0.07)
Market Capitalization
3.2 B
Enterprise Value Revenue
2.8177
Revenue
8.8 B
We have found one hundred twenty available fundamental signals for Bausch Health Companies, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of Bausch Health's prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 9.5 B, whereas Enterprise Value is forecasted to decline to about 17.6 B.

Bausch Health Total Revenue

9.19 Billion

Check Bausch Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bausch main balance sheet or income statement drivers, such as Depreciation And Amortization of 871.5 M, Interest Expense of 1.4 B or Selling General Administrative of 3.1 B, as well as many exotic indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.0117 or Days Sales Outstanding of 95.58. Bausch financial statements analysis is a perfect complement when working with Bausch Health Valuation or Volatility modules.
  
This module can also supplement Bausch Health's financial leverage analysis and stock options assessment as well as various Bausch Health Technical models . Check out the analysis of Bausch Health Correlation against competitors.

Bausch Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets14.9 B27.4 B27 B
Pretty Stable
Short and Long Term Debt Total23.5 B22.4 B20 B
Slightly volatile
Other Current Liabilities1.2 BB2.3 B
Slightly volatile
Total Current Liabilities4.5 B4.3 B3.6 B
Slightly volatile
Property Plant And Equipment Net1.8 B1.7 B1.2 B
Slightly volatile
Net Debt22.5 B21.4 B19.3 B
Slightly volatile
Accounts Payable755 M719 M392.6 M
Slightly volatile
Cash502.7 M947 M735.3 M
Pretty Stable
Non Current Assets Total12.7 B21.8 B23.2 B
Pretty Stable
Non Currrent Assets Other236.2 M307 M377.9 M
Pretty Stable
Cash And Short Term Investments506 M947 M736.3 M
Pretty Stable
Net Receivables2.1 BB1.7 B
Slightly volatile
Common Stock Shares Outstanding246.3 M364.9 M321.2 M
Slightly volatile
Liabilities And Stockholders Equity14.9 B27.4 B27 B
Pretty Stable
Non Current Liabilities Total24.3 B23.1 B22 B
Slightly volatile
Other Current Assets1.1 B1.1 B648 M
Slightly volatile
Other Stockholder Equity203.3 M214 M690.9 M
Slightly volatile
Total Liabilities28.8 B27.4 B25.4 B
Slightly volatile
Property Plant And Equipment GrossB3.8 B1.8 B
Slightly volatile
Total Current Assets5.9 B5.6 B4.1 B
Slightly volatile
Short Term Debt472.5 M450 M319.9 M
Pretty Stable
Intangible Assets5.8 B6.5 B10.3 B
Pretty Stable
Inventory1.6 B1.5 B964.6 M
Slightly volatile
Common Stock Total EquityB11.9 B8.6 B
Slightly volatile
Common Stock6.1 B10.4 B8.4 B
Slightly volatile
Other Liabilities1.3 B1.1 B1.9 B
Very volatile
Long Term Debt14 B21.9 B19.1 B
Slightly volatile
Good Will7.2 B11.2 B10.6 B
Slightly volatile
Property Plant Equipment2.2 B2.1 B1.3 B
Slightly volatile
Long Term Debt Total21.5 B23.4 B19.9 B
Slightly volatile
Capital Surpluse173.7 M182.8 M321.4 M
Pretty Stable
Deferred Long Term Liabilities172.7 M181.8 M1.6 B
Slightly volatile
Long Term Investments5.1 M8.2 M6.8 M
Slightly volatile
Non Current Liabilities Other983.3 MB899.8 M
Slightly volatile
Deferred Long Term Asset Charges97.8 M167.9 M117.6 M
Slightly volatile
Short and Long Term Debt465.3 M450 M314.5 M
Slightly volatile
Cash And Equivalents797.4 M507.6 M768.9 M
Pretty Stable
Net Invested Capital19.9 B21.4 B27.5 B
Slightly volatile
Net Working Capital1.4 B1.3 B581.1 M
Slightly volatile
Capital Stock11.3 B10.4 B10.3 B
Slightly volatile

Bausch Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization871.5 M1.3 B1.6 B
Pretty Stable
Selling General Administrative3.1 B2.9 BB
Slightly volatile
Total Revenue9.2 B8.8 B7.2 B
Slightly volatile
Gross Profit6.5 B6.2 B5.2 B
Slightly volatile
Other Operating Expenses7.5 B7.2 B6.2 B
Slightly volatile
Cost Of Revenue2.7 B2.6 BB
Slightly volatile
Total Operating Expenses4.8 B4.6 B4.2 B
Slightly volatile
Research Development634.2 M604 M388.5 M
Slightly volatile
Selling And Marketing Expenses381.9 M595.7 M317.4 M
Slightly volatile
Non Recurring12.8 M13.5 M610.8 M
Pretty Stable
Interest Income24.7 M26 M776.1 M
Slightly volatile
Reconciled Depreciation1.5 B1.3 B2.3 B
Slightly volatile
Extraordinary Items780 M877.5 M955.5 M
Slightly volatile

Bausch Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow569 M591 M893.2 M
Slightly volatile
Other Cashflows From Financing Activities3.7 B3.2 B7.2 B
Pretty Stable
Depreciation926.7 M1.3 B1.7 B
Pretty Stable
Capital Expenditures170.4 M272 M264.6 M
Pretty Stable
End Period Cash Flow604.5 M962 M933.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.320.33422.4644
Slightly volatile
Dividend Yield0.01170.01230.1222
Slightly volatile
Days Sales Outstanding95.5883.278588.4029
Slightly volatile
EV To Sales2.642.78265.0602
Slightly volatile
Inventory Turnover2.831.65742.6594
Slightly volatile
Days Of Inventory On Hand129220158
Slightly volatile
Payables Turnover3.373.55915.1239
Very volatile
Sales General And Administrative To Revenue0.310.30.2956
Slightly volatile
Research And Ddevelopement To Revenue0.09750.0690.0606
Very volatile
Cash Per Share1.422.59522.1313
Pretty Stable
Days Payables Outstanding148103107
Slightly volatile
Intangibles To Total Assets0.430.64490.6984
Very volatile
Current Ratio1.991.30081.2653
Pretty Stable
Receivables Turnover3.694.38294.1736
Slightly volatile
Graham Number11.0810.111219.5241
Pretty Stable
Revenue Per Share25.223.998420.8
Slightly volatile
Interest Debt Per Share68.2464.993161.2192
Slightly volatile
Debt To Assets0.860.81860.7301
Slightly volatile
Operating Cycle194304241
Pretty Stable
Days Of Payables Outstanding148103107
Slightly volatile
Long Term Debt To Capitalization1.11.04890.9159
Slightly volatile
Total Debt To Capitalization1.11.04780.9171
Slightly volatile
Quick Ratio0.650.68460.7567
Slightly volatile
Cash Ratio0.210.22010.2389
Slightly volatile
Days Of Inventory Outstanding129220158
Slightly volatile
Days Of Sales Outstanding95.5883.278588.4029
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.90.73640.8451
Pretty Stable
Fixed Asset Turnover3.985.13015.5256
Very volatile
Debt Ratio0.860.81860.7301
Slightly volatile
Price Sales Ratio0.320.33422.4644
Slightly volatile
Asset Turnover0.430.32020.2815
Pretty Stable
Gross Profit Margin0.810.70780.7277
Very volatile

Bausch Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.5 B5.8 B14.2 B
Slightly volatile
Enterprise Value17.6 B27.3 B33 B
Very volatile

Bausch Fundamental Market Drivers

Forward Price Earnings2.4108
Cash And Short Term Investments947 M

Bausch Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bausch Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bausch Health income statement, its balance sheet, and the statement of cash flows. Bausch Health investors use historical funamental indicators, such as Bausch Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bausch Health investors may use each financial statement separately, they are all related. The changes in Bausch Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bausch Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bausch Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bausch Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.4 B2.5 B
Total Revenue8.8 B9.2 B
Cost Of Revenue2.6 B2.7 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.31 
Research And Ddevelopement To Revenue 0.07  0.1 
Capex To Revenue(0.03)(0.03)
Revenue Per Share 24.00  25.20 
Ebit Per Revenue 0.11  0.17 

Pair Trading with Bausch Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bausch Stock

  0.76A Agilent Technologies Financial Report 28th of May 2024 PairCorr
  0.76DSGN Design Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Bausch Stock

  0.74BNR Burning Rock BiotechLtd Financial Report 4th of June 2024 PairCorr
  0.56NVS Novartis AG ADR Earnings Call This WeekPairCorr
  0.47VRTX Vertex Pharmaceuticals Financial Report 6th of May 2024 PairCorr
  0.44VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out the analysis of Bausch Health Correlation against competitors.
Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Bausch Stock analysis

When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.115
Earnings Share
(1.62)
Revenue Per Share
23.998
Quarterly Revenue Growth
0.098
Return On Assets
0.0382
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.